Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

177Lu-labeled αPD-L1 antibody synergizes with an immune checkpoint inhibitor for colorectal tumors

Jingyun Ren, Mengxin Xu, Junyi Chen, Jiyuan Li, Peipei Wang, Jie Ding, Li Huo, Fang Li and Zhibo Liu
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1217;
Jingyun Ren
1Peking Union Medical College Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mengxin Xu
2Peking University Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junyi Chen
2Peking University Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiyuan Li
2Peking University Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peipei Wang
1Peking Union Medical College Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie Ding
1Peking Union Medical College Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Huo
1Peking Union Medical College Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fang Li
1Peking Union Medical College Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhibo Liu
2Peking University Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 61 no. supplement 1 1217

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2020.

Copyright & Usage 
© 2020

Author Information

  1. Jingyun Ren1,
  2. Mengxin Xu2,
  3. Junyi Chen2,
  4. Jiyuan Li2,
  5. Peipei Wang1,
  6. Jie Ding1,
  7. Li Huo1,
  8. Fang Li1 and
  9. Zhibo Liu2
  1. 1Peking Union Medical College Hospital Beijing China
  2. 2Peking University Beijing China

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 2020600
Jun 20202600
Jul 20201500
Aug 20202200
Sep 20201300
Oct 20201100
Nov 2020900
Dec 20201000
Jan 2021500
Feb 20211900
Mar 20212000
Apr 20211100
May 20211000
Jun 2021200
Jul 2021800
Aug 2021900
Sep 2021500
Oct 2021900
Nov 2021500
Dec 2021600
Jan 2022400
Feb 2022700
Mar 2022500
Apr 20223000
May 2022800
Jun 20221300
Jul 2022900
Aug 2022900
Sep 20221000
Oct 2022600
Nov 2022300
Dec 2022300
Jan 20231500
Feb 20231400
Mar 20231000
Apr 2023500
May 2023800
Jun 2023900
Jul 2023600
Aug 2023200
Sep 2023200
Oct 2023300
Nov 2023300
Dec 2023500
Jan 2024900
Feb 2024500
Mar 2024700
Apr 20242600
May 20241600
Jun 2024400
Jul 2024900
Aug 2024800
Sep 20241400
Oct 20242000
Nov 20241500
Dec 2024700
Jan 20252700
Feb 2025800
Mar 20251200
Apr 20251300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
177Lu-labeled αPD-L1 antibody synergizes with an immune checkpoint inhibitor for colorectal tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
177Lu-labeled αPD-L1 antibody synergizes with an immune checkpoint inhibitor for colorectal tumors
Jingyun Ren, Mengxin Xu, Junyi Chen, Jiyuan Li, Peipei Wang, Jie Ding, Li Huo, Fang Li, Zhibo Liu
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1217;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
177Lu-labeled αPD-L1 antibody synergizes with an immune checkpoint inhibitor for colorectal tumors
Jingyun Ren, Mengxin Xu, Junyi Chen, Jiyuan Li, Peipei Wang, Jie Ding, Li Huo, Fang Li, Zhibo Liu
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1217;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
  • Simplifying and Confirming Ketosis: A Quality Improvement Initiative in Cardiac Sarcoid Assessment
Show more

Basic Oncology & Translational (Poster Session)

  • Assessment of 18F-fluoroglucaric acid uptake in lung and brain cancer cell lines
  • Impact of ER stress and PI3K-AKT-mTOR inhibitors on NIS glycosylation and subcellular localization in thyroid cell lines
  • Estimating the minimally required tumor perfusion and receptor expression in radioligand therapy using PBPK modeling
Show more Basic Oncology & Translational (Poster Session)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire